172 related articles for article (PubMed ID: 17937607)
1. Defects in homocysteine metabolism: diversity among hyperhomocyst(e)inemias.
Matthews RG; Elmore CL
Clin Chem Lab Med; 2007; 45(12):1700-3. PubMed ID: 17937607
[TBL] [Abstract][Full Text] [Related]
2. The many flavors of hyperhomocyst(e)inemia: insights from transgenic and inhibitor-based mouse models of disrupted one-carbon metabolism.
Elmore CL; Matthews RG
Antioxid Redox Signal; 2007 Nov; 9(11):1911-21. PubMed ID: 17696766
[TBL] [Abstract][Full Text] [Related]
3. Metabolic derangement of methionine and folate metabolism in mice deficient in methionine synthase reductase.
Elmore CL; Wu X; Leclerc D; Watson ED; Bottiglieri T; Krupenko NI; Krupenko SA; Cross JC; Rozen R; Gravel RA; Matthews RG
Mol Genet Metab; 2007 May; 91(1):85-97. PubMed ID: 17369066
[TBL] [Abstract][Full Text] [Related]
4. Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in monkeys with hyperhomocyst(e)inemia or hypercholesterolemia.
Böger RH; Bode-Böger SM; Sydow K; Heistad DD; Lentz SR
Arterioscler Thromb Vasc Biol; 2000 Jun; 20(6):1557-64. PubMed ID: 10845872
[TBL] [Abstract][Full Text] [Related]
5. Genetic and nongenetic factors for moderate hyperhomocyst(e)inemia.
Kang SS; Wong PW
Atherosclerosis; 1996 Jan; 119(2):135-8. PubMed ID: 8808490
[TBL] [Abstract][Full Text] [Related]
6. Pathogenicity of thermolabile methylenetetrahydrofolate reductase for vascular dementia.
Yoo JH; Choi GD; Kang SS
Arterioscler Thromb Vasc Biol; 2000 Aug; 20(8):1921-5. PubMed ID: 10938012
[TBL] [Abstract][Full Text] [Related]
7. Homocysteine: overview of biochemistry, molecular biology, and role in disease processes.
Fowler B
Semin Vasc Med; 2005 May; 5(2):77-86. PubMed ID: 16047261
[TBL] [Abstract][Full Text] [Related]
8. Mutations in methylenetetrahydrofolate reductase or cystathionine beta-synthase gene, or a high-methionine diet, increase homocysteine thiolactone levels in humans and mice.
Chwatko G; Boers GH; Strauss KA; Shih DM; Jakubowski H
FASEB J; 2007 Jun; 21(8):1707-13. PubMed ID: 17327360
[TBL] [Abstract][Full Text] [Related]
9. [Hyperhomocysteinemia: an independent risk factor or a simple marker of vascular disease?. 1. Basic data].
Guilland JC; Favier A; Potier de Courcy G; Galan P; Hercberg S
Pathol Biol (Paris); 2003 Mar; 51(2):101-10. PubMed ID: 12801808
[TBL] [Abstract][Full Text] [Related]
10. Homocysteine metabolism.
Selhub J
Annu Rev Nutr; 1999; 19():217-46. PubMed ID: 10448523
[TBL] [Abstract][Full Text] [Related]
11. Folic acid and homocyst(e)ine metabolic defects and the risk of placental abruption, pre-eclampsia and spontaneous pregnancy loss: A systematic review.
Ray JG; Laskin CA
Placenta; 1999 Sep; 20(7):519-29. PubMed ID: 10452905
[TBL] [Abstract][Full Text] [Related]
12. Influence of oral S-adenosylmethionine on plasma 5-methyltetrahydrofolate, S-adenosylhomocysteine, homocysteine and methionine in healthy humans.
Loehrer FM; Schwab R; Angst CP; Haefeli WE; Fowler B
J Pharmacol Exp Ther; 1997 Aug; 282(2):845-50. PubMed ID: 9262350
[TBL] [Abstract][Full Text] [Related]
13. Derangement of hepatic polyamine, folate, and methionine cycle metabolism in cystathionine beta-synthase-deficient homocystinuria in the presence and absence of treatment: Possible implications for pathogenesis.
Maclean KN; Jiang H; Phinney WN; Mclagan BM; Roede JR; Stabler SP
Mol Genet Metab; 2021 Feb; 132(2):128-138. PubMed ID: 33483253
[TBL] [Abstract][Full Text] [Related]
14. Hyperhomocyst(e)inemia and MTHFR C677T genotypes in patients with central retinal vein occlusion.
Weger M; Stanger O; Deutschmann H; Temmel W; Renner W; Schmut O; Semmelrock J; Haas A
Graefes Arch Clin Exp Ophthalmol; 2002 Apr; 240(4):286-90. PubMed ID: 11981642
[TBL] [Abstract][Full Text] [Related]
15. Endothelial dysfunction and elevation of S-adenosylhomocysteine in cystathionine beta-synthase-deficient mice.
Dayal S; Bottiglieri T; Arning E; Maeda N; Malinow MR; Sigmund CD; Heistad DD; Faraci FM; Lentz SR
Circ Res; 2001 Jun; 88(11):1203-9. PubMed ID: 11397788
[TBL] [Abstract][Full Text] [Related]
16. Asymmetric dimethyl-L-arginine (ADMA): a possible link between homocyst(e)ine and endothelial dysfunction.
Stühlinger MC; Stanger O
Curr Drug Metab; 2005 Feb; 6(1):3-14. PubMed ID: 15720202
[TBL] [Abstract][Full Text] [Related]
17. Causes and consequences of hyperhomocyst(e)inemia.
Pietrzik K; Brönstrup A
Int J Vitam Nutr Res; 1997; 67(5):389-95. PubMed ID: 9350483
[TBL] [Abstract][Full Text] [Related]
18. Treatment of hyperhomocyst(e)inemia: physiological basis.
Kang SS
J Nutr; 1996 Apr; 126(4 Suppl):1273S-5S. PubMed ID: 8642469
[TBL] [Abstract][Full Text] [Related]
19. Hyperhomocyst(e)inemia and a common methylenetetrahydrofolate reductase mutation (Ala223Val MTHFR) in patients with inherited thrombophilic coagulation defects.
Legnani C; Palareti G; Grauso F; Sassi S; Grossi G; Piazzi S; Bernardi F; Marchetti G; Ferraresi P; Coccheri S
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2924-9. PubMed ID: 9409277
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms in MTHFR, MS and CBS genes and homocysteine levels in a Pakistani population.
Yakub M; Moti N; Parveen S; Chaudhry B; Azam I; Iqbal MP
PLoS One; 2012; 7(3):e33222. PubMed ID: 22470444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
